Sat | Dec 6, 2025

CDC tells states to be ready for November 1 distribution of vaccines

Published:Thursday | September 3, 2020 | 8:40 AM
In this August 14, 2020, file photo, laboratory technicians work at the Abxience biopharmaceutical company on an experimental coronavirus vaccine developed by Oxford University and the laboratory AstraZeneca in Garin, Argentina. AstraZeneca announced Monday, August 31, 2020, its vaccine candidate has entered the final testing stage in the US. (AP Photo/Natacha Pisarenko, File)

PROVIDENCE, Rhode Island (AP) — The federal government has told states to prepare for a coronavirus vaccine to be ready to distribute by November 1.

The timeline raised concern among public health experts about an “October surprise” — a vaccine approval driven by political considerations ahead of a presidential election, rather than science.

In a letter to governors dated August 27, Robert Redfield, director of the US Centers for Disease Control and Prevention, said states “in the near future” will receive permit applications from McKesson Corp., which has contracted with CDC to distribute vaccines to places including state and local health departments and hospitals.

“CDC urgently requests your assistance in expediting applications for these distribution facilities and, if necessary, asks that you consider waiving requirements that would prevent these facilities from becoming fully operational by November 1, 2020,” Redfield wrote.

He wrote that any waivers will not compromise the safety or effectiveness of the vaccine. The Associated Press obtained the letter, which was first reported by McClatchy.

The CDC also sent three planning documents to some health departments that included possible timelines for when vaccines would be available.

The documents are to be used to develop plans for early vaccination when the supply might be constrained, according to one of the documents, which outlined a scenario in which a vaccine could be available as soon as the end of October.

“The COVID-19 vaccine landscape is evolving and uncertain, and these scenarios may evolve as more information is available,” the document reads.

Another of the documents says that limited COVID-19 vaccine doses may be available by early November and that supply will increase substantially in 2021.

It also states that initially available vaccines will either be approved by the Food and Drug Administration or authorised by the agency under its emergency powers.

The documents encourage health officials to work out now which groups to prioritise for a vaccine, identify providers who will administer vaccine, and take other steps to prepare.

The planning documents were first reported by The New York Times.

Follow The Gleaner on Twitter and Instagram @JamaicaGleaner and on Facebook @GleanerJamaica. Send us a message on WhatsApp at 1-876-499-0169 or email us @onlinefeedback@gleanerjm.com or editors@gleanerjm.com.